ANVISA
- Status: likely_approved
🇧🇷 Exondys 51 in Brazil
Exondys 51 (ETEPLIRSEN) regulatory status in Brazil.
Marketing authorisation
Exondys 51 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in Brazil
Frequently asked questions
Is Exondys 51 approved in Brazil?
Yes. ANVISA has authorised it.
Who is the marketing authorisation holder for Exondys 51 in Brazil?
Sarepta is the originator. The local marketing authorisation holder may differ — check the official source linked above.